BioSpace News Archive

Pharm Country

Axon Therapies Announces Positive Results From First-In-Human Clinical Study in Late-Breaking Clinical Trial Session At 2020 Virtual HFSA Conference

Axon Therapies, a Coridea portfolio company focused on addressing one of the root causes of heart failure, today announced positive interim results from their first-in-human (FIH) trial of splanchnic ablation for volume management, or SAVM, using the Satera™ Ablation System.

October 9, 2020
·
3 min read
Business

careMESH Appoints new Chief Technology Officer

careMESH today announced that Gustavo Bonany has been appointed as chief technology officer (CTO).

October 9, 2020
·
2 min read
Genetown

Alexion Announces Upcoming Data Presentations at the American Society of Nephrology’s Virtual Kidney Week 2020

- Four abstracts accepted for presentation, including new clinical trial analyses that provide further support for the safety and efficacy of ULTOMIRIS ® (ravulizumab-cwvz) for the treatment of pediatric patients with atypical hemolytic uremic syndrome (aHUS) - BOSTON--( BUSINESS WIRE )-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that four abstracts have been accepted for presentation at the American Society of Nephrology’s Kidne

October 9, 2020
·
23 min read